FOREST CABIN (02657) has released its interim results for 2026, posting revenue of 1.4997 billion yuan, a 42.6% year-on-year increase, with net profit reaching 256 million yuan, up 40.7% from the prior corresponding period.

Basic earnings per share stood at 1.81 yuan. The revenue growth was primarily driven by higher sales of essence oils, lotions, toners, and creams, which benefited from the launch of new SKUs boosting product volume and the upgrade of existing core hero products.

The company has established a comprehensive sales network, strategically integrating diverse online channels with a robust offline presence through deep online-offline convergence. This omnichannel approach has not only enhanced consumer engagement with the brand but also fueled sustainable growth across all sales channels.

In addition, FOREST CABIN places a strong emphasis on R&D innovation, viewing it as the cornerstone of its brand competitiveness. Its R&D efforts are primarily self-driven, complemented by strategic collaborations, focusing on the in-depth exploration and application of Camellia extract and related skincare technologies, while continuously iterating product development based on consumer needs.

As of June 30, 2026, the company employed 151 experienced R&D personnel, with expertise spanning botany, biology, dermatology, and applied chemistry, of whom over 58% hold a master's degree or higher, ensuring the professionalism and forward-looking nature of its research activities.

In terms of R&D investment, development costs for the reported period amounted to 34 million yuan, up 88.8% year-on-year, reflecting the company's long-term commitment to technological innovation.